I noted at the beginning of this month that AIM-listed Advanced Oncotherapy (AVO) needs to get a fundraise away pronto, but that its shares were threatening to drop below the nominal price of 25p, below which it cannot issue new shares by law. On Friday the shares closed at 24p (mid) and I would suggest that Advanced – or, rather, its shareholders – have a big problem.

The FCA has today indicated that it will not object to the proposed recapitalization and customer redress package proposed by loan shark Amigo (AMGO) but there are a few horrid caveats and a doubling of the share price to 6p is quite literally insane making this a slam dunk short. Here’s why.

Normally companies will do anything they can to stop auditors or anyone else saying that there is any uncertainty at all as to its ability to continue as a going concern, that is to say not to go bust causing investors to lose all their money. But today, loan shark Amigo (AMGO) stresses most clearly that there is a material uncertainty and still its shares are bid higher. Crazy stuff.

So much for the spike in Amigo (AMGO) shares yesterday in the belief that the Court would agree to its plans to pay customers it had ripped off only very partial compensation. The FCA opposed the scheme since it sees those ripped off getting only partial redress while equity holders keep the rest of the cash stolen by Amigo. And the Court, it emerged this morning, agrees with the FCA and myself and Justice Mills slates Amigo. As for foul mouthed bear raider Evil Knievil…

This all looks a bit of a mess. Loan shark Amigo (AMGO) needs Court approval for a scheme whereby customers it screwed get only partial compensation. Those customers have been bullied into voting for it by directors making the threat that if the plan is not accepted the. Amigo will put itself into administration meaning shareholders and screwed customers get nothing. The FCA has objected as the directors are lying, there is a fairer way.

Everyone knows that loan shark Amigo (AMGO) screwed tens of thousands of customers. Even the company admits to it. Shareholders benefited from that screw. Amigo wants to pay out just a portion of that screw in compensation, leaving shareholders taking no pain as they get to keep some of the ill-gotten gains. Quite rightly those folks at the FCA have taken a few minutes from wanking off on ESG porn to put a stop to this.

Last night, at 5.32pm on a Friday – no-one-is-watching o’clock – AIM-listed John Zorbas outfit URU Metals (URU) issued an RNS related to its death spiral financing package first announced in May last year. It is good news for the loan sharks, but surely shareholders deserve better.

AIM-listed technically insolvent John Zorbas POS URU Metals (URU) announced yesterday that it has for the second time extended the initial 90-day initial notice period on its convertible death-spiral loan by a further 90 days. With the shares at 260p, the initial deal to convert the loan is massively more attractive for the loan shark than the 35% discount that would otherwise apply – so why is URU doing this?

Of course that is not what Benamor intends to do but it is what he achieves in a long diatribe posted on the internet in which he, naturally, paints himself as the hero of the tale.

What a complete and total POS. As I pointed out (yet again) yesterday, AIM-listed URU Metals (URU) was technically insolvent and for no apparent reason the shares had marched up to 200p, overvaluing this outfit by…..er….200p. Needless to say, the directors had a duty to raise money and at no-one-is-watching o’clock last night (4.56pm) we learnt that they had. But the company misleads over the massive 57.5% discount – and that is a best case scenario – and the company is STILL technically insolvent.

Yesterday I pointed out how the £13 million death spiral Advanced Oncotherapy (AVO) had signed with loan sharks Bracknor would see its share price collapse. It should but there is worse news in store - that of insolvency looming in just five weeks time. Insolvency you say? What are you talking about? Let me explain.